This live symposium will be held adjunct to the 2019 American College
of Physicians Internal Medicine Meeting
CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CME?src=hash" target="_blank"gt;#CMElt;/agt;–Physicians’ Education Resource® (PER®), a worldwide leader in continuing
medical education (CME), will conduct a live CME-accredited activity,
“Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs
to Know,” as a satellite symposium adjunct to the 2019 American College
of Physicians Internal Medicine Meeting. The symposium will take place
Wednesday, April 10, from 7 to 9 p.m. at the Philadelphia Marriott
Downtown and will be chaired by James A. Underberg, M.D., M.S.,
FACPM, FACP, FNYAM, FASPC, FNLA, clinical assistant professor of
medicine, NYU School of Medicine & NYU Center for Prevention of
Cardiovascular Disease and director, Bellevue Hospital Lipid Clinic.
“Although many doctors prescribe statins to help lower cholesterol
levels in patients, a large portion of these patients remain at residual
cardiovascular disease risk,” said Phil Talamo, president of PER®. “This
program will explore the latest cholesterol-lowering national guidelines
and evidence for non-statin options for patients who are not reaching
lipid-lowering goals.”
In this engaging, interactive, case-based symposium, a panel of renowned
experts in dyslipidemia management will review the latest clinical trial
data on PCSK9 inhibitors and provide insights into the most challenging
lipid-lowering scenarios for managing patients with CVD. Those who
attend this symposium will hear expert interpretation of the latest
cholesterol-lowering guidelines, receive guidance on issues of statin
intolerance and severe hypercholesterolemia, learn evidence-based
strategies for management of dyslipidemia with non-statin therapies, and
be updated on indications for PCSK9 inhibitors and real-world
experience, as well as have an opportunity to network with peers.
This live activity is accredited by the Accreditation Council for
Continuing Medical Education for 2.0 AMA PRA Category 1 Credits™ for
physicians. For more information and to register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care
through professional education and now furthers patient care and
treatment strategies on a wide variety of chronic illnesses and
diseases. In 2016, PER® initiated continuing medical
education (CME) programming in the cardiovascular and endocrinology
areas. While continuing to expand into topics outside of oncology, PER®
remains the leading provider of live, online and print CME activities
related to oncology and hematology. The high-quality, evidence-based
activities feature leading distinguished experts who focus on the
application of practice-changing advances. PER® is accredited
by the Accreditation Council for Continuing Medical Education and the
California Board of Registered Nursing. PER® is part of the
Cranbury, New Jersey-based MJH Associates, Inc., family of businesses.
Learn more at http://www.gotoper.com
and http://www.mjhassoc.com.
Contacts
PER® Media Contacts
Alexandra Ventura, 609-716-7777,
ext. 121
aventura@mjhassoc.com
John
Patricolo, 609-325-4630
jpatricolo@mjhassoc.com